Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / An Evidence-Based Review of Elagolix for the Treatment of Pain Secondary to Endometriosis.

< BACK TO ARCHIVE


2020 Oct 15


Psychopharmacol Bull


http://www.ncbi.nlm.nih.gov/pubmed/33633426?dopt=Abstract


50


4 Suppl 1

An Evidence-Based Review of Elagolix for the Treatment of Pain Secondary to Endometriosis.

Authors

An Evidence-Based Review of Elagolix for the Treatment of Pain Secondary to Endometriosis.
Urits I, Adamian L, Miro P, Callan J, Patel PM, Patel M, Berger AA, Kassem H, Kaye AD, Viswanath O
Psychopharmacol Bull. 2020 Oct 15; 50(4 Suppl 1):197-215.
PMID: 33633426.

Abstract

This is a review of elagolix use for pain related to endometriosis. It summarizes the background and recent data available about the pathogenesis of endometriosis and pain that is secondary to this syndrome. It then reviews the evidence to support the use of elagolix and the indications for use.